The impact of COVID-19 on acute stroke care in Belgium.

Belgium COVID-19 pandemic Door-to-groin puncture time Door-to-needle time Stroke care

Journal

Acta neurologica Belgica
ISSN: 2240-2993
Titre abrégé: Acta Neurol Belg
Pays: Italy
ID NLM: 0247035

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 26 04 2021
accepted: 10 06 2021
pubmed: 21 6 2021
medline: 24 9 2021
entrez: 20 6 2021
Statut: ppublish

Résumé

A worldwide decline in stroke hospitalizations during the COVID-19 pandemic has been reported. Information on stroke care during the pandemic in Belgium is lacking. This study aims to analyze the impact of COVID-19 on acute stroke care in eight Belgian stroke centers. This Belgian study is part of an international observational and retrospective study in 70 countries and 457 stroke centers. We compared volumes of COVID-19 and stroke hospitalizations, intravenous thrombolysis and endovascular treatment rates, acute treatment time intervals and functional outcome at 90 days during the first wave of the pandemic to two control intervals (March-May 2019 and December-February 2020). From March 2020 to May 2020, 860 stroke patients were hospitalized. In the same time period, 2850 COVID-19 patients were admitted, of which 37 (1.3%) were diagnosed with a stroke. Compared to the months prior to the pandemic and the same time epoch one year earlier, stroke hospitalizations were reduced (relative difference 15.9% [p = 0.03] and 14.5% [p = 0.05], respectively). Despite a reduction in absolute volumes, there was no difference in the monthly proportion of thrombolysis or endovascular treatment provided to the overall stroke hospitalizations. Acute treatment time metrics did not change between COVID-19 pandemic and control time epochs. We found no difference in 90-day functional outcomes nor in mortality after stroke between patients admitted during the pandemic versus control periods. We found a decline in the volume of stroke hospitalizations during the first wave of the COVID-19 pandemic in Belgium. Stroke care quality parameters remained unchanged.

Identifiants

pubmed: 34148220
doi: 10.1007/s13760-021-01726-x
pii: 10.1007/s13760-021-01726-x
pmc: PMC8214455
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1251-1258

Informations de copyright

© 2021. Belgian Neurological Society.

Références

Emanuel EJ, Persad G, Upshur R et al (2020) Fair allocation of scarce medical resources in the time of Covid-19. New Engl J Med. 382(21):2049–2055. https://doi.org/10.1056/NEJMsb2005114
doi: 10.1056/NEJMsb2005114 pubmed: 32202722
WHO Director-General (2020) WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Helms J, Kremer S, Merdji H et al (2020) Neurologic features in severe SARS-CoV-2 infection. New Engl J Med 382(23):2268–2270. https://doi.org/10.1056/NEJMc2008597
doi: 10.1056/NEJMc2008597 pubmed: 32294339
Abdalkader M, Shaikh SP, Siegler JE et al (2021) Cerebral venous sinus thrombosis in COVID-19 patients: a multicenter study and review of literature. J Stroke Cerebrovasc Dis 30(6):105733. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105733.PubMedPMID:33743411;PubMedCentralPMCID:PMCPMC7931726.eng
doi: 10.1016/j.jstrokecerebrovasdis.2021.105733.PubMedPMID:33743411;PubMedCentralPMCID:PMCPMC7931726.eng pubmed: 33743411 pmcid: 7931726
Hernández-Fernández F, Sandoval Valencia H, Barbella-Aponte RA et al (2020) Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain 143(10):3089–3103. https://doi.org/10.1093/brain/awaa239 (PubMedPMID:32645151;PubMedCentralPMCID:PMCPMC7454411.eng)
doi: 10.1093/brain/awaa239 pubmed: 32645151
Elkind Mitchell SV, Boehme Amelia K, Smith Craig J et al (2020) Infection as a stroke risk factor and determinant of outcome after stroke. Stroke 51(10):3156–3168. https://doi.org/10.1161/STROKEAHA.120.030429
doi: 10.1161/STROKEAHA.120.030429 pubmed: 32897811
Tsivgoulis G, Katsanos Aristeidis H, Ornello R et al (2020) Ischemic stroke epidemiology during the COVID-19 pandemic. Stroke 51(7):1924–1926. https://doi.org/10.1161/STROKEAHA.120.030791
doi: 10.1161/STROKEAHA.120.030791 pubmed: 32496937
Siegler JE, Cardona P, Arenillas JF et al (2020) Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry. Int J Stroke 30:1747493020959216. https://doi.org/10.1177/1747493020959216 (PubMedPMID:32852257;PubMedCentralPMCID:PMCPMC7533468.eng)
doi: 10.1177/1747493020959216
Ntaios G, Michel P, Georgiopoulos G et al (2020) Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke. Stroke 51(9):e254–e258. https://doi.org/10.1161/STROKEAHA.120.031208
doi: 10.1161/STROKEAHA.120.031208 pubmed: 32787707
Zhao J, Li H, Kung D et al (2020) Impact of the COVID-19 epidemic on stroke care and potential solutions. Stroke 51(7):1996–2001. https://doi.org/10.1161/STROKEAHA.120.030225
doi: 10.1161/STROKEAHA.120.030225 pubmed: 32432997
Rudilosso S, Laredo C, Vera V et al (2020) Acute Stroke Care Is at Risk in the Era of COVID-19. Stroke 51(7):1991–1995. https://doi.org/10.1161/STROKEAHA.120.030329
doi: 10.1161/STROKEAHA.120.030329 pubmed: 32438895
Kristoffersen ES, Jahr SH, Thommessen B et al (2020) Effect of COVID-19 pandemic on stroke admission rates in a Norwegian population. Acta Neurol Scand 2020142(6):632–636. https://doi.org/10.1111/ane.13307
doi: 10.1111/ane.13307
Kerleroux B, Fabacher T, Bricout N et al (2020) Mechanical thrombectomy for acute ischemic stroke amid the COVID-19 outbreak. Stroke 51(7):2012–2017. https://doi.org/10.1161/STROKEAHA.120.030373
doi: 10.1161/STROKEAHA.120.030373 pubmed: 32432994
Ma A, Kase CS, Shoamanesh A et al (2021) Stroke and Thromboprophylaxis in the Era of COVID-19. J Stroke Cerebrovasc Dis 30(1):105392–105392. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105392.PubMedPMID:33130478;eng
doi: 10.1016/j.jstrokecerebrovasdis.2020.105392.PubMedPMID:33130478;eng pubmed: 33130478
Nogueira RG, Abdalkader M, Qureshi MM et al (2021) Global impact of COVID-19 on stroke care. Int J Stroke 29:1747493021991652. https://doi.org/10.1177/1747493021991652 (PubMedPMID:33459583;PubMedCentralPMCID:PMCPMC8010375.eng)
doi: 10.1177/1747493021991652
Nogueira RG, Qureshi MM, Abdalkader M et al (2021) Global Impact of COVID-19 on stroke care and intravenous thrombolysis. Neurology. https://doi.org/10.1212/wnl.0000000000011885 (PubMedPMID:33766997;eng)
doi: 10.1212/wnl.0000000000011885 pubmed: 33766997 pmcid: 7846488
Banks Jamie L, Marotta CA (2007) Outcomes validity and reliability of the modified rankin scale: implications for stroke clinical trials. Stroke 38(3):1091–1096. https://doi.org/10.1161/01.STR.0000258355.23810.c6
doi: 10.1161/01.STR.0000258355.23810.c6 pubmed: 17272767
Yaghi S, Ishida K, Torres J et al (2020) SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke 51(7):2002–2011. https://doi.org/10.1161/STROKEAHA.120.030335
doi: 10.1161/STROKEAHA.120.030335 pubmed: 32432996
Uchino K, Kolikonda Murali K, Brown D et al (2020) Decline in stroke presentations during COVID-19 surge. Stroke 51(8):2544–2547. https://doi.org/10.1161/STROKEAHA.120.030331
doi: 10.1161/STROKEAHA.120.030331 pubmed: 32716818
Siegler JE, Heslin ME, Thau L et al (2020) Falling stroke rates during COVID-19 pandemic at a comprehensive stroke center. J Stroke Cerebrovasc Dis 29(8):104953–104953. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104953 (PubMedPMID:32689621;eng)
doi: 10.1016/j.jstrokecerebrovasdis.2020.104953 pubmed: 32689621 pmcid: 7221408
Sacco S, Ricci S, Ornello R et al (2020) Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy. Stroke 51(12):3746–3750. https://doi.org/10.1161/strokeaha.120.031293.PubMedPMID:33059543;PubMedCentralPMCID:PMCPMC7678662.eng
doi: 10.1161/strokeaha.120.031293.PubMedPMID:33059543;PubMedCentralPMCID:PMCPMC7678662.eng pubmed: 33059543 pmcid: 7678662
Rinkel LA, Prick JCM, Slot RER et al (2021) Impact of the COVID-19 outbreak on acute stroke care. J Neurol 268(2):403–408. https://doi.org/10.1007/s00415-020-10069-1
doi: 10.1007/s00415-020-10069-1 pubmed: 32691235
Hsiao J, Sayles E, Antzoulatos E et al (2020) Effect of COVID-19 on Emergent Stroke Care. Stroke 51(9):e2111–e2114. https://doi.org/10.1161/STROKEAHA.120.030499
doi: 10.1161/STROKEAHA.120.030499 pubmed: 32639860
Hoyer C, Ebert A, Huttner HB et al (2020) Acute Stroke in Times of the COVID-19 pandemic: a multicenter study. Stroke 51(7):2224–2227. https://doi.org/10.1161/strokeaha.120.030395PubMedPMID:32516064;eng (PubMedPMID:32516064;eng)
doi: 10.1161/strokeaha.120.030395 pubmed: 32516064
Gdovinová Z, Vitková M, Baráková A et al (2020) The impact of the COVID-19 outbreak on acute stroke care in Slovakia: Data from across the country. Eur J Neurol. https://doi.org/10.1111/ene.14640 (PubMedPMID:33185918;eng)
doi: 10.1111/ene.14640 pubmed: 33185918
Diegoli H, Magalhães PSC, Martins SCO et al (2020) Decrease in Hospital admissions for transient ischemic attack, mild, and moderate stroke during the COVID-19 era. Stroke 51(8):2315–2321. https://doi.org/10.1161/strokeaha.120.030481 (PubMedPMID:32530738;PubMedCentralPMCID:PMCPMC7302100.eng)
doi: 10.1161/strokeaha.120.030481 pubmed: 32530738
Desai SM, Guyette FX, Martin-Gill C et al (2020) Collateral damage - Impact of a pandemic on stroke emergency services. J Stroke Cerebrovasc Dis 29(8):104988–104988. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104988.PubMedPMID:32689650;eng (PubMedPMID:32689650;eng)
doi: 10.1016/j.jstrokecerebrovasdis.2020.104988 pubmed: 32689650 pmcid: 7284271
Siegler JE, Zha AM, Czap AL et al (2021) Influence of the COVID-19 Pandemic on treatment times for acute ischemic stroke: the society of vascular and interventional neurology multicenter collaboration. Stroke 52(1):40–47
doi: 10.1161/STROKEAHA.120.032789
Wu Y, Chen F, Wang Z et al (2020) Reductions in Hospital admissions and delays in acute stroke care during the pandemic of COVID-19 [Original Research]. Front Neurol. https://doi.org/10.3389/fneur.2020.584734 ((English)@)
doi: 10.3389/fneur.2020.584734 pubmed: 33584527 pmcid: 7779790
Mafham MM, Spata E, Goldacre R et al (2020) COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet 396(10248):381–389. https://doi.org/10.1016/S0140-6736(20)31356-8
doi: 10.1016/S0140-6736(20)31356-8 pubmed: 32679111 pmcid: 7429983
Nguyen TN, Haussen DC, Qureshi MM et al (2021) Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic. Stroke Vasc Neurol. https://doi.org/10.1136/svn-2020-000695 (PubMedPMID:33771936;PubMedCentralPMCID:PMCPMC8006491.eng)
doi: 10.1136/svn-2020-000695 pubmed: 33771936
Friedlich D, Newman T, Bricker S (2021) Impact of the COVID-19 pandemic on stroke epidemiology and clinical stroke practice in the US. J Stroke Cerebrovasc Dis. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105639 (PubMed PMID: 105639)
doi: 10.1016/j.jstrokecerebrovasdis.2021.105639 pubmed: 34256928 pmcid: 8271905
Grewal P, Pinna P, Hall JP et al (2020) Acute Ischemic Stroke and COVID-19: Experience From a Comprehensive Stroke Center in Midwest US. Front Neurol 11:910–910. https://doi.org/10.3389/fneur.2020.00910.PubMedPMID:32973666;eng (PubMedPMID:32973666;eng)
doi: 10.3389/fneur.2020.00910 pubmed: 32973666 pmcid: 7468395
Fuentes B, Alonso de Leciñana M, García-Madrona S et al (2021) Stroke Acute management and outcomes during the COVID-19 outbreak. Stroke 52(2):552–562. https://doi.org/10.1161/STROKEAHA.120.031769
doi: 10.1161/STROKEAHA.120.031769 pubmed: 33406872
Calmettes J, Peres R, Goncalves B et al (2021) Clinical outcome of acute ischemic strokes in patients with COVID-19. Cerebrovasc Dis. https://doi.org/10.1159/000514562
doi: 10.1159/000514562 pubmed: 33784669
Perry RJ, Smith CJ, Roffe C et al (2021) Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study. J Neurol Neurosurg Psychiatry 92(3):242. https://doi.org/10.1136/jnnp-2020-324927
doi: 10.1136/jnnp-2020-324927 pubmed: 33154179
de Havenon A, Yaghi S, Mistry EA et al (2020) Endovascular thrombectomy in acute ischemic stroke patients with COVID-19: prevalence, demographics, and outcomes. J Neurointerv Surg 12(11):1045–1048. https://doi.org/10.1136/neurintsurg-2020-016777.PubMedPMID:32989032;PubMedCentralPMCID:PMCPMC7523171.eng (PubMedPMID:32989032;PubMedCentralPMCID:PMCPMC7523171.eng)
doi: 10.1136/neurintsurg-2020-016777 pubmed: 32989032

Auteurs

Vincent Raymaekers (V)

Department of Neurology, Groeninge Hospital, Kortrijk, Belgium. vincent.raymaekers@azgroeninge.be.
Faculty of Medicine and Health Sciences, Antwerp University, Antwerp, Belgium. vincent.raymaekers@azgroeninge.be.

Jelle Demeestere (J)

Department of Neurology, Leuven University Hospital, Leuven, Belgium.

Flavio Bellante (F)

Department of Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium.

Sofie De Blauwe (S)

Department of Neurology, Sint-Jan Hospital Bruges-Ostend, Bruges, Belgium.

Sylvie De Raedt (S)

Department of Neurology, University Hospital Brussels, Jette, Belgium.
Center of Neurosciences, University of Brussels, Brussels, Belgium.

Anne Dusart (A)

Department of Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium.

Lise Jodaitis (L)

Department of Neurology, Erasmus Hospital, Brussels, Belgium.

Robin Lemmens (R)

Department of Neurology, Leuven University Hospital, Leuven, Belgium.

Caroline Loos (C)

Faculty of Medicine and Health Sciences, Antwerp University, Antwerp, Belgium.
Department of Neurology, Antwerp University Hospital, Edegem, Belgium.

Ligot Noémie (L)

Department of Neurology, Erasmus Hospital, Brussels, Belgium.

Matthieu P Rutgers (MP)

Department of Neurology, Europe Hospitals, Brussels, Belgium.

Fenne Vandervorst (F)

Department of Neurology, University Hospital Brussels, Jette, Belgium.
Center of Neurosciences, University of Brussels, Brussels, Belgium.

Geert Vanhooren (G)

Department of Neurology, Sint-Jan Hospital Bruges-Ostend, Bruges, Belgium.

Laetitia Yperzeele (L)

Faculty of Medicine and Health Sciences, Antwerp University, Antwerp, Belgium.
Department of Neurology, Antwerp University Hospital, Edegem, Belgium.

Raul G Nogueira (RG)

Department of Neurology, Grady Memorial Hospital, Emory University, Atlanta, GA, USA.

Thanh N Nguyen (TN)

Department of Neurology, Radiology, Boston Medical Center, Boston University School of Medicine, Boston, USA.

Peter Vanacker (P)

Department of Neurology, Groeninge Hospital, Kortrijk, Belgium.
Faculty of Medicine and Health Sciences, Antwerp University, Antwerp, Belgium.
Department of Neurology, Antwerp University Hospital, Edegem, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH